• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 B100 基因敲除仓鼠:一种具有显性遗传和饮食诱导冠状动脉粥样硬化的家族性高胆固醇血症的啮齿动物模型。

LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis.

机构信息

Institute of Cardiovascular Sciences, Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing 100191, China.

Lipid Metabolism Laboratory, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang, China.

出版信息

EBioMedicine. 2018 Jan;27:214-224. doi: 10.1016/j.ebiom.2017.12.013. Epub 2017 Dec 15.

DOI:10.1016/j.ebiom.2017.12.013
PMID:29289533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5828369/
Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease caused mainly by LDL receptor (Ldlr) gene mutations. Unlike FH patients, heterozygous Ldlr knockout (KO) mice do not show a dominant FH trait. Hamsters, like humans, have the cholesteryl ester transfer protein, intestine-only ApoB editing and low hepatic cholesterol synthesis. Here, we generated Ldlr-ablated hamsters using CRISPR/Cas9 technology. Homozygous Ldlr KO hamsters on a chow diet developed hypercholesterolemia with LDL as the dominant lipoprotein and spontaneous atherosclerosis. On a high-cholesterol/high-fat (HCHF) diet, these animals exhibited severe hyperlipidemia and atherosclerotic lesions in the aorta and coronary arteries. Moreover, the heterozygous Ldlr KO hamsters on a short-term HCHF diet also had overt hypercholesterolemia, which could be effectively ameliorated with several lipid-lowering drugs. Importantly, heterozygotes on 3-month HCHF diets developed accelerated lesions in the aortas and coronary arteries. Our findings demonstrate that the Ldlr KO hamster is an animal model of choice for human FH and has great potential in translational research of hyperlipidemia and coronary heart disease.

摘要

家族性高胆固醇血症(FH)是一种常染色体显性遗传疾病,主要由 LDL 受体(Ldlr)基因突变引起。与 FH 患者不同,杂合子 Ldlr 基因敲除(KO)小鼠不表现出显性 FH 特征。仓鼠与人类一样,具有胆固醇酯转移蛋白、肠型 ApoB 编辑和低肝胆固醇合成。在这里,我们使用 CRISPR/Cas9 技术生成了 Ldlr 基因敲除的仓鼠。在普通饮食中,杂合子 Ldlr KO 仓鼠发生高胆固醇血症,以 LDL 为主的脂蛋白和自发性动脉粥样硬化。在高胆固醇/高脂肪(HCHF)饮食中,这些动物表现出严重的高脂血症和主动脉及冠状动脉的动脉粥样硬化病变。此外,短期 HCHF 饮食的杂合子 Ldlr KO 仓鼠也表现出明显的高胆固醇血症,几种降脂药物可有效改善。重要的是,接受 3 个月 HCHF 饮食的杂合子仓鼠在主动脉和冠状动脉的病变进展加快。我们的研究结果表明,Ldlr KO 仓鼠是人类 FH 的首选动物模型,在高脂血症和冠心病的转化研究中有很大的潜力。

相似文献

1
LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis.载脂蛋白 B100 基因敲除仓鼠:一种具有显性遗传和饮食诱导冠状动脉粥样硬化的家族性高胆固醇血症的啮齿动物模型。
EBioMedicine. 2018 Jan;27:214-224. doi: 10.1016/j.ebiom.2017.12.013. Epub 2017 Dec 15.
2
Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters.饮食胆固醇与杂合子 LDLR 缺陷型仓鼠高脂血症严重程度和动脉粥样硬化病变高度相关。
Int J Mol Sci. 2019 Jul 18;20(14):3515. doi: 10.3390/ijms20143515.
3
Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.缺乏低密度脂蛋白受体 (LDLR) 外显子 7 的兔自发性严重高胆固醇血症和动脉粥样硬化病变。
EBioMedicine. 2018 Oct;36:29-38. doi: 10.1016/j.ebiom.2018.09.020. Epub 2018 Sep 19.
4
In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.体内 AAV-CRISPR/Cas9 介导的基因编辑改善家族性高胆固醇血症中的动脉粥样硬化。
Circulation. 2020 Jan 7;141(1):67-79. doi: 10.1161/CIRCULATIONAHA.119.042476. Epub 2019 Nov 29.
5
Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR/Cas9 gene editing system.采用多重 sgRNA 靶向 CRISPR/Cas9 基因编辑系统生成高脂血症兔模型。
Lipids Health Dis. 2019 Mar 18;18(1):69. doi: 10.1186/s12944-019-1013-8.
6
An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency.低密度脂蛋白受体缺陷型家族性高胆固醇血症动物模型中脂质谱与动脉粥样硬化的种间研究。
Am J Transl Res. 2019 May 15;11(5):3116-3127. eCollection 2019.
7
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient ( and ) Yucatan Miniature Pigs.贝匹地酸降低 LDL 胆固醇并减轻 LDL 受体缺陷(和)尤卡坦小型猪的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1178-1190. doi: 10.1161/ATVBAHA.117.310676. Epub 2018 Feb 15.
8
Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia.载脂蛋白 E 基因缺失可预防家族性高胆固醇血症仓鼠模型的自发性动脉粥样硬化
Oxid Med Cell Longev. 2022 May 24;2022:1889632. doi: 10.1155/2022/1889632. eCollection 2022.
9
Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.低密度脂蛋白受体的靶向破坏会导致尤卡坦小型猪出现高胆固醇血症和动脉粥样硬化。
PLoS One. 2014 Apr 1;9(4):e93457. doi: 10.1371/journal.pone.0093457. eCollection 2014.
10
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.4名纯合子家族性高胆固醇血症患者的表型变异性,这些患者为低密度脂蛋白受体(LDLR)突变的复合杂合子。
J Clin Lipidol. 2016 Jul-Aug;10(4):944-952.e1. doi: 10.1016/j.jacl.2016.04.005. Epub 2016 Apr 21.

引用本文的文献

1
Gene editing therapy as a therapeutic approach for cardiovascular diseases in animal models: A scoping review.基因编辑疗法作为动物模型中心血管疾病的一种治疗方法:一项范围综述。
PLoS One. 2025 Jun 4;20(6):e0325330. doi: 10.1371/journal.pone.0325330. eCollection 2025.
2
Targeted disruption of the aralkylamine -acetyltransferase gene in a seasonal mammal, .在一种季节性哺乳动物中对芳烷基胺-N-乙酰转移酶基因进行靶向破坏。
PNAS Nexus. 2025 May 20;4(6):pgaf159. doi: 10.1093/pnasnexus/pgaf159. eCollection 2025 Jun.
3
Hypercholesterolemia, oxidative stress, and low-grade inflammation: a potentially dangerous scenario to blood-brain barrier.

本文引用的文献

1
Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.他汀类药物长期治疗冠心病的疗效与安全性:一项贝叶斯网络荟萃分析。
Atherosclerosis. 2016 Nov;254:215-227. doi: 10.1016/j.atherosclerosis.2016.10.025. Epub 2016 Oct 14.
2
Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?Apoe-/-和Ldlr-/-小鼠对动脉粥样硬化发生机制的见解相同吗?
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1734-41. doi: 10.1161/ATVBAHA.116.306874. Epub 2016 Jul 7.
3
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality.
高胆固醇血症、氧化应激和低度炎症:对血脑屏障而言的潜在危险情形。
Metab Brain Dis. 2025 May 17;40(5):205. doi: 10.1007/s11011-025-01620-y.
4
A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY.一种天然小分子异银杏双黄酮通过靶向ACLY减轻高胆固醇血症和动脉粥样硬化。
Theranostics. 2025 Mar 18;15(10):4325-4344. doi: 10.7150/thno.105782. eCollection 2025.
5
Genomic-transcriptomic analysis identifies the Syrian hamster as a superior animal model for human diseases.基因组-转录组分析确定叙利亚仓鼠是人类疾病的优质动物模型。
BMC Genomics. 2025 Mar 24;26(1):286. doi: 10.1186/s12864-025-11393-4.
6
Fat-1 Ameliorates Metabolic Dysfunction-Associated Fatty Liver Disease and Atherosclerosis through Promoting the Nuclear Localization of PPARα in Hamsters.Fat-1通过促进仓鼠体内PPARα的核定位改善代谢功能障碍相关的脂肪性肝病和动脉粥样硬化。
Research (Wash D C). 2025 Mar 6;8:0577. doi: 10.34133/research.0577. eCollection 2025.
7
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease.运动蛋白KIF13B协调肝脏代谢以预防代谢功能障碍相关脂肪性肝病。
Mil Med Res. 2025 Mar 4;12(1):11. doi: 10.1186/s40779-025-00594-3.
8
Impaired inflammatory resolution with severe SARS-CoV-2 infection in leptin knock out obese hamster.瘦素基因敲除肥胖仓鼠感染严重严重急性呼吸综合征冠状病毒2(SARS-CoV-2)后炎症消退受损。
iScience. 2025 Jan 17;28(2):111837. doi: 10.1016/j.isci.2025.111837. eCollection 2025 Feb 21.
9
ApoL1 risk allele accelerates high-fat diet-induced atherosclerosis in LDLR hamsters.载脂蛋白L1风险等位基因加速低密度脂蛋白受体缺陷仓鼠的高脂饮食诱导动脉粥样硬化。
Genes Dis. 2024 Jul 23;12(2):101379. doi: 10.1016/j.gendis.2024.101379. eCollection 2025 Mar.
10
Development of a hamster model of spontaneous hypertriglyceridemia in diabetes.糖尿病自发性高甘油三酯血症仓鼠模型的建立。
Animal Model Exp Med. 2024 Dec;7(6):955-960. doi: 10.1002/ame2.12490. Epub 2024 Nov 12.
低密度脂蛋白胆固醇、治疗策略及其对心血管疾病发病率和死亡率影响的综述。
J Clin Lipidol. 2016 May-Jun;10(3):472-89. doi: 10.1016/j.jacl.2015.11.010. Epub 2015 Nov 25.
4
Development of Human-Like Advanced Coronary Plaques in Low-Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques.低密度脂蛋白受体基因敲除猪中类人高级冠状动脉斑块的形成及动脉粥样硬化斑块形成前他汀类药物治疗的理由
J Am Heart Assoc. 2016 Apr 18;5(4):e002779. doi: 10.1161/JAHA.115.002779.
5
Human Validation of Genes Associated With a Murine Atherosclerotic Phenotype.与小鼠动脉粥样硬化表型相关基因的人体验证
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1240-6. doi: 10.1161/ATVBAHA.115.306958. Epub 2016 Apr 14.
6
Cholesterol confusion and statin controversy.胆固醇的困惑与他汀类药物的争议。
World J Cardiol. 2015 Jul 26;7(7):404-9. doi: 10.4330/wjc.v7.i7.404.
7
Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.基于指南的他汀类药物适用情况、冠状动脉钙化与心血管事件
JAMA. 2015 Jul 14;314(2):134-41. doi: 10.1001/jama.2015.7515.
8
Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.通过改变胆固醇酯转运蛋白(CETP)的底物偏好来修饰其功能:CETP药物设计的新范式
J Lipid Res. 2015 Mar;56(3):612-619. doi: 10.1194/jlr.M056333. Epub 2015 Jan 23.
9
Efficient gene targeting in golden Syrian hamsters by the CRISPR/Cas9 system.利用CRISPR/Cas9系统在金黄叙利亚仓鼠中实现高效基因靶向
PLoS One. 2014 Oct 9;9(10):e109755. doi: 10.1371/journal.pone.0109755. eCollection 2014.
10
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.纯合子家族性高胆固醇血症:临床医生提高检测和临床管理水平的新见解与指南。欧洲动脉粥样硬化学会家族性高胆固醇血症共识小组的立场文件。
Eur Heart J. 2014 Aug 21;35(32):2146-57. doi: 10.1093/eurheartj/ehu274. Epub 2014 Jul 22.